<DOC>
	<DOCNO>NCT02704598</DOCNO>
	<brief_summary>This prospective , randomize study , aim evaluate patient Deep Venous Thrombosis low limbs recanalization rate evaluate DUPLEX ultrasound , clinical outcome patient submit oral anticoagulation Rivaroxaban versus Warfarin .</brief_summary>
	<brief_title>Comparison Between Xarelto Versus Warfarin Recanalization Rate Deep Venous Thrombosis Patients Legs .</brief_title>
	<detailed_description>In study patient low limbs deep venous thrombosis assign randomize two group : Group 1 - Patients submit oral anticoagulation Rivaroxaban ( Xarelto ) least 6 month . Group 2 - Patients undergoing oral anticoagulation Warfarin 6 month . These two drug approve FDA treatment deep venous thrombosis . The primary outcome assign recanalization rate vein two group , use Duplex ultrasound . The patient also evaluate within symptom , clinical sign , edema , limb swelling , pain , return habitual activity . Inclusion criterion : deep venous thrombosis patient important disease , cancer , thrombophilic state , age 80 . Exclusion criterion : cancer , thrombophilic state , mental disorder , age superior 80 year , contraindication oral anticoagulation . The primary outcome within 1 year Deep venous thrombosis .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Rivaroxaban</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients deep venous thrombosis lower limb . Patients cancer , mental disorder , thrombophilic disorder contraindication anticoagulation therapy , pregnant woman .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>